The Mekong Region: Lao PDR Sharing Border with Cambodia, China, Myanmar, Thailand and Vietnam.

<p>Source: <a href="https://www.cia.gov/library/publications/cia-maps-publications/Laos.html" target="_blank">https://www.cia.gov/library/publications/cia-maps-publications/Laos.html</a>.</p

Number of distributed influenza A(H1N1) pandemic vaccine doses by target population, 2009–2010 Lao PDR.

<p>Source: Lao PDR National Immunization Program (NIP), Annual Report on NIP 2010. Date: 20 January 2011, Anonh Xeuatvongsa, Director of National Immunization Program, Ministry of Health, Vientiane, Lao Peoples Democratic Republic, email address: <a href="mailto:[email protected]" target="_blank">[email protected]</a>; Data submitted to through WHO: <a href="http://www.who.int/influenza_vaccines_plan/resources/h1n1_deployment_report.pdf" target="_blank">http://www.who.int/influenza_vaccines_plan/resources/h1n1_deployment_report.pdf</a>.</p><p>^aOther Essential Personnel include essential government workers as designated by the GOL</p><p>^bNot Applicable</p><p>^cNo Data</p><p>Number of distributed influenza A(H1N1) pandemic vaccine doses by target population, 2009–2010 Lao PDR.</p

Characteristics of seasonal influenza vaccine use among the nine Southeast Asian countries that responded to study survey<b>.</b>

*<p>Due to chronic metabolic diseases (including diabetes mellitus), renal dysfunction, haemoglobinopathies or immunosuppression (including by medication or HIV).</p>†<p>High risk conditions: Malaysia (chronic cardiovascular, pulmonary, metabolic or renal disease, or who are immunocompromised); Philippines (chronic pulmonary or cardiovascular disorders); Singapore (diseases of the pulmonary or cardiovascular systems, including asthma); Thailand (chronic obstructive pulmonary disease, asthma, heart disease, stroke, kidney failure, cancer, diabetes, thalassemia, immunosuppression including persons infected with HIV); Vietnam (COPD, congenital heart disease, heart failure, diabetes, immunodeficiency).</p>**<p>Only includes elderly with >1 more of the following chronic conditions: chronic cardiovascular, pulmonary, metabolic or renal disease, or who are immunocompromised.</p

Reported AEFIs by Targeted Populations Surveyed.

<p>Lao PDR National Immunization Program (NIP), Anonh Xeuatvongsa, Director of National Immunization Program, Ministry of Health, Lao Peoples Democratic Republic, email address: <a href="mailto:[email protected]" target="_blank">[email protected]</a>.</p

Influenza vaccine sales per 100,000 population; shaded areas are aggregate data from several countries. Dashed line (–) indicates data were not available.

†<p>Private sales data in this row are from Thailand Food and Drug Administration.</p>*<p>Excludes Brunei.</p

Selected health, budgetary, and immunization statistics of the ten Southeast Asian countries surveyed.

<p>GNI: Gross National Income; DGP: Gross Domesitc Product; USD: United States Dollars.</p>1<p>Total gross national income per-capita, total expenditure on health, percent of deaths among children <5 years caused by pneumonia and ranking of pneumonia as the cause of childhood mortality updated May 2012 and found at: levels for each country found at: <a href="http://www.who.int/countries/en/" target="_blank">http://www.who.int/countries/en/</a>.</p>2<p>World Bank country classification can be found at: <a href="http://data.worldbank.org/about/country-classifications/country-and-lending-groups" target="_blank">http://data.worldbank.org/about/country-classifications/country-and-lending-groups</a>.</p>3<p>Routine childhood vaccinations are tuberculosis (BCG), diptheria, tetanus, pertussis (DTP), oral polio vaccine (OPV), hepatitis B, and measles-containing vaccine (MCV).</p>4<p>Percent of routine vaccinations funded by government and under 5-year mortality rates updated Oct 2012 and found at: <a href="http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileselect.cfm" target="_blank">http://apps.who.int/immunization_monitoring/en/globalsummary/countryprofileselect.cfm</a>.</p

Crude proportion of respiratory samples from hospitalized children testing positive for influenza by age group, study design, and population.

<p>Crude proportion of respiratory samples from hospitalized children testing positive for influenza by age group, study design, and population.</p

Flow diagram for systematic review process.

<p>Flow diagram for systematic review process.</p

Pooled estimates of global pediatric influenza-associated hospitalizations per year, by age group, development status, and WHO region, among studies using PCR diagnostic testing.

<p>Pooled estimates of global pediatric influenza-associated hospitalizations per year, by age group, development status, and WHO region, among studies using PCR diagnostic testing.</p

Characteristics of published studies and surveillance data sources about influenza-associated respiratory illness among hospitalized children, 1982–2012.

<p>Characteristics of published studies and surveillance data sources about influenza-associated respiratory illness among hospitalized children, 1982–2012.</p